Svoboda | Graniru | BBC Russia | Golosameriki | Facebook

To install click the Add extension button. That's it.

The source code for the WIKI 2 extension is being checked by specialists of the Mozilla Foundation, Google, and Apple. You could also do it yourself at any point in time.

4,5
Kelly Slayton
Congratulations on this excellent venture… what a great idea!
Alexander Grigorievskiy
I use WIKI 2 every day and almost forgot how the original Wikipedia looks like.
Live Statistics
English Articles
Improved in 24 Hours
Added in 24 Hours
Languages
Recent
Show all languages
What we do. Every page goes through several hundred of perfecting techniques; in live mode. Quite the same Wikipedia. Just better.
.
Leo
Newton
Brights
Milds

Rodolphe Barrangou

From Wikipedia, the free encyclopedia

Rodolphe Barrangou
Alma mater
Scientific career
Institutions

Rodolphe Barrangou is the Todd R. Klaenhammer Distinguished Professor in Probiotics Research in the Department of Food, Bioprocessing and Nutrition Sciences at North Carolina State University; Co-Founder and Chief Executive Officer of CRISPR Biotechnologies; Co-Founder and Chief Scientific Officer of Ancilia Biosciences; Co-Founder, President and Chief Scientific Officer of TreeCo; and Co-Founder and member of the Scientific Advisory Board of Intellia Therapeutics. His research focuses on CRISPR-Cas9 in bacteria.[1]

In 2017, Barrangou was named[2] Editor-in-Chief of The CRISPR Journal, a peer-reviewed journal covering the field of genome editing and CRISPR research, which debuted in February 2018.

He was elected as a member into the National Academy of Sciences in 2018.[3] He was also elected into the National Academy of Engineering in 2019 for the discovery of CRISPR-Cas genome editing and engineering microbes, plants, and animals for food and other applications.

YouTube Encyclopedic

  • 1/3
    Views:
    52 031
    2 437
    749
  • The CRISPR Apostle: Rodolphe Barrangou
  • Rodolphe Barrangou
  • Rodolphe Barrangou - NAS Prize in Food and Agriculture Sciences

Transcription

Background

Dr Barrangou's research has been funded by the National Institutes of Health, National Science Foundation, US Department of Agriculture, and institutional grants.[4] He previously worked as an adjunct professor of Food Science at Pennsylvania State University, and R&D Director of Genomics at DuPont.

In 2007, Barrangou was the first author on a paper published in Science providing experimental proof for the immune function of CRISPR.[5] He has worked with Jennifer Doudna on Cas9 guided RNA characterization. He has been awarded 17 patents as of 2016.[4]

Education

Awards

References

  1. ^ "Rodolphe Barrangou – NC State University". Food, Bioprocessing and Nutrition Sciences. 18 September 2017. Retrieved 13 December 2021.
  2. ^ "Rodolphe Barrangou, PhD, appointed Editor-in-Chief of The CRISPR Journal". www.liebertpub.com.
  3. ^ "May 1 2018 NAS Election". National Academy of Sciences. 1 May 2018. Retrieved 13 December 2021.
  4. ^ a b Barrangou CV
  5. ^ Barrangou, Rodolphe; Fremaux, Christophe; Deveau, Hélène; Richards, Melissa; Boyaval, Patrick; Moineau, Sylvain; Romero, Dennis A.; Horvath, Philippe (2007-03-23). "CRISPR provides acquired resistance against viruses in prokaryotes". Science. 315 (5819): 1709–1712. Bibcode:2007Sci...315.1709B. doi:10.1126/science.1138140. hdl:20.500.11794/38902. ISSN 1095-9203. PMID 17379808. S2CID 3888761.
This page was last edited on 3 August 2024, at 19:28
Basis of this page is in Wikipedia. Text is available under the CC BY-SA 3.0 Unported License. Non-text media are available under their specified licenses. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc. WIKI 2 is an independent company and has no affiliation with Wikimedia Foundation.